Background-Capsaicin protects the
Aim/method-To investigate the effect of capsaicin, cimetidine, and in combination, given intragastrically in the healing of acetic acid induced chronic gastric ulcer in the rat. Treatment started immediately after ulcer induction. Results-At the end ofone week, capsaicin, cimetidine, and in combination increased ulcer healing but the effect of combined treatment was less than that of capsaicin alone. In an in vivo gastric chamber preparation, capsaicin increased, while cimetidine decreased, gastric mucosal blood flow measured by laser Doppler flowmetry. A dose response effect in reduction of gastric mucosal blood flow could be demonstrated for cimetidine. The gastric hyperaemic effect of capsaicin was blunted by prior administration of cimetidine. In contrast, capsaicin had no effect on gastric acid secretion and its addition to cimetidine did not affect the acid suppressant effect of the latter. Conclusions-Capsaicin promotes the healing of acetic acid induced gastric ulcer, probably by its gastric hyperaemic effect. Although cimetidine also promotes ulcer healing due to its inhibitory effect on acid secretion it may have an antagonistic effect on the gastric ulcer healing effect of capsaicin by virtue of inhibition of gastric hyperaemia. (Gut 1996; 38: 832-836) Capsaicin has a gastroprotective effect and reduces the amount of gastric mucosal injury produced by various necrotising agents such as ethanol and aspirin.1-3 Sensory ablation by capsaicin impairs recovery from gastric mucosal damage produced by hydrochloric acid4 and acetic acid induced ulceration,5 although the process ofrapid restitution remains unaffected. 6 The use of exogenous capsaicin in animals with intact innervation to promote the healing of experimental gastric ulcer has not, however, been studied to our knowledge. Suppressants of gastric acid secretion, in contrast, are known to increase the healing of both human and experimental gastric ulcer.7 8 The aims of this study are, firstly, to determine the effect of capsaicin on the healing of acetic acid induced gastric ulceration in the rat, comparing this effect with that of cimetidine, an inhibitor of gastric acid secretion widely used in human peptic ulcer disease, and evaluating the effect of combined treatment, and secondly, to determine the effect of capsaicin, cimetidine, and combined treatment on gastric mucosal blood flow and gastric acid output as possible mechanisms by which ulcer healing may be promoted.
Methods

GASTRIC ULCER HEALING
Animal preparation Male Sprague-Dawley rats weighing approximately 200 g were used for this study. They were acclimatised in the animal house for one week prior to the study. Chronic gastric ulcers were produced by direct application of acetic acid using a modification of the method previously described by Okabe9 and Konturek.10 General anaesthesia was induced by intraperitoneal administration of pentobarbitone 35 mg/kg. Laparotomy was performed through a midline epigastric incision and the stomach exposed. A plastic mould of 10 mm diameter was applied tightly to the serosal surface of the anterior wall of the stomach just proximal to the antrum and 120 KI glacial acetic acid was poured through the mould onto the surface of the stomach for 20 seconds. The procedure was then repeated for the posterior wall of the stomach. The abdomen was closed with catgut and silk. The body temperature of the animals was kept at 37°C and the animals were allowed to recover from the anaesthesia. They were then divided into four groups and given unlimited normal diet and water for the next seven days.
Experimental protocol
The animals were divided into four groups and treated daily by gavage with either 1 ml of solvent, 5 12 KHz and the time constant 1.5 second. The zero value was defined by placing the laser prove against a white board. The probe was placed just above the perpendicular to the mucosal surface and its position fixed by a metal stand. Measurements were made continuously and at the same site at the anterior wall of the glandular part of the stomach. The readings were transferred on to floppy disks for subsequent analysis. Areas
Capsaicin solvent
Group 2 Capsaicin
Group 3 Cimetidine
Group 4 Capsaicin Cimetidine under the curve were derived in arbitrary units for quantification of gastric mucosal blood flow over defined time periods.
Experimental protocol
Effect of capsaicin, cimetidine, and combined treatment (study A) -after a stabilising period of at least 30 minutes recording of blood flow was begun and continued for up to 135 minutes. Gastric contents were gently aspirated from the chamber every 15 minutes for pH analysis. Basal blood flow was recorded for 30 minutes. The animals were studied in five groups of eight. For each group one of the following was introduced into the chamber at the end of the basal period: (1) 2 ml capsaicin solvent; (2) 5 mg of capsaicin in 2 ml solvent; (3) 40 mg of cimetidine suspended in 2 ml capsaicin solvent; (4) 5 mg of capsaicin in 2 ml solvent followed 15 minutes later by 40 mg of cimetidine suspended in 2 ml solvent; (5) 40 mg of cimetidine suspended in 2 ml capsaicin solvent followed 15 minutes later by 5 mg of capsaicin in 2 ml solvent. Each solution was removed at the end of 15 minutes and replaced with normal saline. In the case of groups 4 and 5, the first solution or suspension was introduced after 30 minutes of basal recording, removed after another 15 minutes, and the second solution or suspension introduced. Blood flow changes due to various test substances were studied after 45 minutes for groups 1-3 but after 30 minutes for groups 4 and 5 (Fig 1) .
Dose response study for cimetidine (study B) -the gastric mucosal blood flow study was repeated using four different doses of cimetidine (20 mg, 40 mg, 80 mg, and 160 mg), as well as solvent and capsaicin as controls.
MEASUREMENT OF GASTRIC ACID SECRETION
Throughout the basal and test periods gastric juice was gently aspirated every 15 minutes and replaced with normal saline. Gastric acid secretion was measured by titrating the gastric juice to pH 7 with 0.05 N NaOH using an auto-titrator (Radiometer Co, Copenhagen, Denmark).
REAGENTS
Capsaicin, cimetidine, and TWEEN 80 reagents were purchased from Sigma Chemicals (St Louis, USA). Capsaicin and cimetidine were dissolved and suspended respectively in a solvent consisting of 10% ethanol, 10% TWEEN 80, and 80% distilled water, volume for volume. CRC cocktail comprised a mixture of 1 ml of Hypnorm (Janssens, Beerse) that contained 0.315 mg of fentanyl and 10 mg of fluanisone, plus 1 ml of midazolam (Roche, Basel) that contained 5 mg of dormicum, diluted to a 4 ml volume with distilled water. For 100 grams of rat, 0.3 ml of the cocktail was used, containing 0.024 mg of fentanyl, 0.75 mg fluanisone, and 0-38 mg of midazolam. Pentobarbitone sodium was obtained as veterinary nembutal (Abbotts, Paris).
The first reading of gastric blood flow was taken as the basal blood flow. Subsequent readings of blood flow taken at 15 minute intervals were expressed as percentages of the basal blood flow. Areas under the curve were calculated for the 90 minute periods after exposure to the test substance, or the first test substance. For comparison of acid secretion in study A, the total amounts of gastric juice collected over the pre-and post-treatment periods were compared. For each group two 15 minute collections prior to treatment were considered, plus five 15 minute collections after treatment. For the control, capsaicin, cimetidine, and cimetidine plus capsaicin groups, the post-treatment collection began immediately after the introduction of the only or first test substance. For the capsaicin plus cimetidine group, however, only the five treatment periods after cimetidine were considered. The 15 minute period after capsaicin use but before cimetidine was given was not taken into account. For study B, two 15 minute collections made before treatment and six after were studied.
Statistical analysis was performed using the Statistical Package for Social Sciences for Windows (SPSSWIN). One way analysis of variance was performed to detect statistical differences between the groups. Where treatment of data requiring non-parametric techniques was needed, the variables were ranked and analyses performed on the ranked data. This was to avoid the use of the non-parametric Kruskal-Wallis test, which yields a x2 statistic with one degree of freedom. Analysis of variance on ranked data gives a more rigorous test as it uses the F test.12 Probability values less than 0.05 were considered significant.
Results
GASTRIC ULCER HEALING
Five of 45 animals who underwent induction of gastric ulcer did not recover from the anaesthetic. These 40 animals survived the one week of the experiment but in one rat dense adhesions around the stomach precluded satisfactory dissection and measurement of ulcer size. Overall, the animals grew from a mean body weight of 209-9 g to a mean weight of 234.1 g. There was no difference in weight gain between the four groups of animals. Other workers have shown that the initial area of ulcers measured one day after acetic acid induction was similar to the size of the mould.13 The The rate of blood flow remained steady for the control group throughout the 120 minute period of study. The use of capsaicin increased blood flow over control values (Fig 2) . Exposure to cimetidine reduced blood flow rates from those of the control group (Fig 2) . With combined treatment using both capsaicin and cimetidine the results were different depending on the order of administration (Fig 3) . capsaicin groups (mean (SEM)) were: 39.0 (1OK1) ,umol, 43.7 (1 10) ,umol, 0 5 (0.4) pumol (p<005 versus control, capsaicin, capsaicin plus cimetidine, and cimetidine plus capsaicin groups), 6 .7 (2.9) pumol (p<0 05 versus control, capsaicin, and cimetidine groups), and 3.2 (6.3) ,umol (p<005 versus control, capsaicin, and cimetidine groups). Cimetidine is a histamine 2 receptor antagonist, which inhibits gastric acid output and is widely used for the treatment of peptic ulcer in humans.7 It is also known to accelerate the healing of experimental gastric ulcer. 8 We therefore chose to compare cimetidine with capsaicin in this respect. As expected cimetidine at a dose of 40 mg daily did increase ulcer healing compared with control animals. Oral capsaicin at a dose of 5 mg daily also improved ulcer healing. Unexpectedly, combination treatment using capsaicin and cimetidine, while still effective compared with the control group, was less efficacious than the use of capsaicin alone.
Capsaicin is known to increase gastric blood flow and this is thought to be one mechanism for its gastroprotective effect.' In contrast, cimetidine has previously been shown to reduce gastric mucosal blood flow,16 a finding confirmed in this study. We therefore investigated the effect of combined treatment on gastric mucosal blood flow. To measure gastric acid secretion, the solution bathing the gastric chamber preparation has to be aspirated at regular intervals. To eliminate the possibility of the capsaicin and cimetidine solutions interacting physically during the 15 minutes in the gastric chamber, we gave the two solutions consecutively rather than simultaneously. Pilot studies suggested that the sequence of administration made a difference to the effect of combination treatment on mucosal blood flow. Application of cimetidine after hyperaemia had already been initiated with capsaicin did not have any significant effect on subsequent gastric mucosal blood flow. However, the use of cimetidine followed by capsaicin abolished the hyperaemic effect of the latter. Cimetidine can therefore prevent the hyperaemic effect of capsaicin but cannot reverse hyperaemia once it has occurred. The pharmacological basis of this interaction remains to be worked out.
Published works on the effect of capsaicin on gastric acid output are confusing. Basal acid output is not affected either by desensitisation or by intragastric capsaicin administration. [17] [18] [19] [20] However, pentagastrin stimulated gastric acid output was said to be increased,21 or reduced'7 by intragastric capsaicin administration while capsaicin desensitisation either reduced '9 pentagastrin stimulated acid output, or had no effect. 9 Differences in the experimental protocol, for example, use of anaesthesia, or the dosages of pentagastrin may have accounted for some of these differences. In contrast, calcitonin gene related peptide, which is released by capsaicin from sensory nerves and which is thought to be a mediator of capsaicin induced gastric hyperaemia and gastroprotection, has been shown by several groups to inhibit both basal and stimulated gastric acid secretion. [22] [23] [24] It would seem that any effect of capsaicin on gastric acid output may not be relevant to its gastroprotective properties. As expected, application of capsaicin in our gastric chamber preparation had no effect on acid output but cimetidine use reduced gastric acid secretion in a dose related fashion. Addition of capsaicin to cimetidine did not affect the inhibiting effect of the latter or acid secretion. We postulate that the antagonistic effect on ulcer healing of cimetidine when combined with capsaicin is due to reduction of gastric blood flow by cimetidine.
Combined administration of cimetidine with epidermal growth factor, also an ulcer healing agent'0 and stimulator of gastric mucosal blood flow,25 increased the healing of experimental gastric ulcer compared with administration of each substance alone.8 Other histamine 2 receptor antagonists do not have the same effect as cimetidine on gastric mucosal blood flow. Burimamide, for example increased gastric blood flow26 while metiamide,26 ranitidine,27 and ebrotidine27 had no effect. It remains to be seen whether combination treatment using capsaicin plus epidermal growth factor or histamine 2 antagonists other than cimetidine will increase the rate of ulcer healing compared with single agent treatment.
